Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Advances in Neuroimmunology|January 1, 1995
Role of nitric oxide in cell-mediated tumor cytotoxicityM G Cifone, L Cironi, M A Meccia, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 25, 2010
Effects of cadmium on cytotoxic functions of human natural killer cellsM G Cifone, T Napolitano, C Festuccia, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2001
Melanoma cells stimulate osteoclastogenesis, c-Src expression and osteoblast cytokinesM Perez, S Migliaccio, A Taranta, et al.
Endocrine-Related Cancer|December 3, 2005
Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell linesC Festuccia, P Muzi, D Millimaggi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2003
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitroI Recchia, N Rucci, C Festuccia, et al.
Journal of Cardiovascular Translational Research|December 19, 2012
Vitamin D protects human endothelial cells from H₂O₂ oxidant injury through the Mek/Erk-Sirt1 axis activationLorella Polidoro, G Properzi, F Marampon, et al.
Oncology Reports|September 30, 2010
The impact of conventional or hypofractionated radiotherapy on voice quality and oncological outcome in patients with early glottic cancerL Di Nicola, G L Gravina, F Marampon, et al.
Journal of Cellular Physiology|March 29, 2007
PPARbeta agonists trigger neuronal differentiation in the human neuroblastoma cell line SH-SY5YS Di Loreto, B D'Angelo, M A D'Amico, et al.
Prostate Cancer and Prostatic Diseases|June 24, 2009
Subjective and objective measures of late genitourinary morbidity following hypofractionated radiotherapy in men with prostate cancerV Tombolini, M Di Staso, P Bonfili, et al.
Journal of Cellular Physiology|May 1, 2008
Biomolecular characterization of human glioblastoma cells in primary cultures: differentiating and antiangiogenic effects of natural and synthetic PPARgamma agonistsE Benedetti, R Galzio, B Cinque, et al.
Pageof 5